Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty

Rashmi R. Shah, Peter D. Stonier
  • Therapeutic Advances in Drug Safety, June 2018, SAGE Publications
  • DOI: 10.1177/2042098618780854

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1177/2042098618780854

In partnership with: